AAV Gene Therapy Corrects OTC Deficiency and Prevents Liver Fibrosis in Aged OTC-knock Out Heterozygous Mice

Molecular Genetics and Metabolism - United States
doi 10.1016/j.ymgme.2017.02.011
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

174. Liver Fibrosis in Aged OTC-KO Heterozygotes and Successful Correction by AAV8-Mediated Gene Therapy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

Efficient Mitochondrial Import of Newly Synthesized Ornithine Transcarbamylase (OTC) and Correction of Secondary Metabolic Alterations in Spfash Mice Following Gene Therapy of OTC Deficiency

Molecular Medicine
Molecular MedicineGeneticsMolecular Biology
1999English

Molecular Study of Ornithine Transcarbamylase: Otc Deficiency and Analysis of Mitochondrial Targeting of the Otc Precursor

Pediatric Research
Child HealthPediatricsPerinatology
1987English

OTC Statins

Hospital Pharmacy
PharmacologyPharmacy
2005English

Peroxisome Deficiency-Induced ER Stress and SREBP-2 Pathway Activation in the Liver of Newborn PEX2 Knock-Out Mice

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids
Cell BiologyMolecular Biology
2012English

Managing Counterparty Risk in OTC Markets

Finance and Economics Discussion Series
2018English

PHP83 the OTC Policy in Eyrope and Greece

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Financial Intermediation Chains in an OTC Market

2018English

Ornithine Transcarbamylase (OTC) in White Blood Cells

Pediatric Research
Child HealthPediatricsPerinatology
1980English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy